163 related articles for article (PubMed ID: 4875709)
1. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
Loubatières A; Mariani MM; Alric R
Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
[No Abstract] [Full Text] [Related]
2. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
Seltzer HS; Crout JR
Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
[No Abstract] [Full Text] [Related]
3. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
[No Abstract] [Full Text] [Related]
4. [Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide].
Frerichs H; Gerber R; Creutzfeldt W
Diabetologia; 1966 Dec; 2(4):269-76. PubMed ID: 4902707
[No Abstract] [Full Text] [Related]
5. Biochemical aspects of the hyperglycemic action of diazoxide.
Senft G
Ann N Y Acad Sci; 1968 Apr; 150(2):242-55. PubMed ID: 4299217
[No Abstract] [Full Text] [Related]
6. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
Loubatiéres A; Mariani MM
Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
[No Abstract] [Full Text] [Related]
7. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
[No Abstract] [Full Text] [Related]
8. Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system.
Porte D; Robertson RP
Fed Proc; 1973 Jul; 32(7):1792-6. PubMed ID: 4352448
[No Abstract] [Full Text] [Related]
9. Studies on the mechanism of xylitol-induced insulin secretion in dogs. Effect of its infusion into the pancreatic artery, and the inhibition by epinephrine and diazoxide of xylitol-induced hyperinsulinaemia.
Kuzuya T; Kanazawa Y
Diabetologia; 1969 Aug; 5(4):248-57. PubMed ID: 4902720
[No Abstract] [Full Text] [Related]
10. The morphological substrate of the inhibition of insulin secretion by diazoxide.
Creutzfeldt W; Creutzfeldt C; Frerichs H; Perings E; Sicklinger K
Horm Metab Res; 1969 Mar; 1(2):53-64. PubMed ID: 4334867
[No Abstract] [Full Text] [Related]
11. AO44: an improved hyperglycemic agent.
Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
[No Abstract] [Full Text] [Related]
12. [Mechanism of action of a hyperglycemic sulfonamide, Diazoxide].
Loubatières A; Mariani MM; Alric R; Ribes G; De Malbosc H; Chapal J
Ann Endocrinol (Paris); 1966; 27(6):787-94. PubMed ID: 5339929
[No Abstract] [Full Text] [Related]
13. Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide.
Anderson JH; Byrd GW; Blackard WG
Metabolism; 1971 Nov; 20(11):1023-30. PubMed ID: 4329940
[No Abstract] [Full Text] [Related]
14. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
Mariot P; Gilon P; Nenquin M; Henquin JC
Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741
[TBL] [Abstract][Full Text] [Related]
15. Insulinotropic effect and possible mode of action of a new potent sulfonylurea (BS-4231).
Brisson GR; Malaisse WJ
Can J Physiol Pharmacol; 1971 Jun; 49(6):536-44. PubMed ID: 4932540
[No Abstract] [Full Text] [Related]
16. [Morphology and histochemistry of insulin secretion].
Creutzfelt W
Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():387-416. PubMed ID: 4313827
[No Abstract] [Full Text] [Related]
17. Diazoxide and the secretion of insulin.
Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
[No Abstract] [Full Text] [Related]
18. Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli.
Henquin JC; Charles S; Nenquin M; Mathot F; Tamagawa T
Diabetes; 1982 Sep; 31(9):776-83. PubMed ID: 6131003
[No Abstract] [Full Text] [Related]
19. [The effect of diazoxide on glucagon-induced insulin secretion].
Brech WJ; Kaess H; Schlierf G; Rohs M
Klin Wochenschr; 1968 Apr; 46(8):449-50. PubMed ID: 4879594
[No Abstract] [Full Text] [Related]
20. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G
Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
